# Asana, Inc.: financial statements, quarterly

ASAN · NYSE · CIK 1477720 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/asan.md) · [Financials](/companies/asan/financials.md) · [Filings](/companies/asan/filings.md) · [Insiders](/companies/asan/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/asan/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [167](/filings/0001477720-24-000107.md) | [171 d](/filings/0001477720-26-000021.md) | [172](/filings/0001477720-25-000107.md) | [179](/filings/0001477720-25-000200.md) | [184](/filings/0001477720-25-000237.md) | [188 d](/filings/0001477720-26-000021.md) | [187](/filings/0001477720-26-000039.md) | [197](/filings/0001477720-26-000060.md) | [201](/filings/0001477720-25-000237.md) | [206 d](/filings/0001477720-26-000021.md) | [205](/filings/0001477720-26-000039.md) | [216](/filings/0001477720-26-000060.md) |
| Cost of revenue | $m | [16.1](/filings/0001477720-24-000107.md) | [17.4 d](/filings/0001477720-26-000021.md) | [17.8](/filings/0001477720-25-000107.md) | [20.0](/filings/0001477720-25-000200.md) | [19.8](/filings/0001477720-25-000237.md) | [19.6 d](/filings/0001477720-26-000021.md) | [19.2](/filings/0001477720-26-000039.md) | [20.2](/filings/0001477720-26-000060.md) | [22.3](/filings/0001477720-25-000237.md) | [25.0 d](/filings/0001477720-26-000021.md) | [25.4](/filings/0001477720-26-000039.md) | [30.3](/filings/0001477720-26-000060.md) |
| Gross profit | $m | [150](/filings/0001477720-24-000107.md) | [154 d](/filings/0001477720-26-000021.md) | [155](/filings/0001477720-25-000107.md) | [159](/filings/0001477720-25-000200.md) | [164](/filings/0001477720-25-000237.md) | [169 d](/filings/0001477720-26-000021.md) | [168](/filings/0001477720-26-000039.md) | [177](/filings/0001477720-26-000060.md) | [179](/filings/0001477720-25-000237.md) | [181 d](/filings/0001477720-26-000021.md) | [180](/filings/0001477720-26-000039.md) | [186](/filings/0001477720-26-000060.md) |
| Research and development | $m | [81.0](/filings/0001477720-24-000107.md) | [83.0 d](/filings/0001477720-26-000021.md) | [82.8](/filings/0001477720-25-000107.md) | [91.2](/filings/0001477720-25-000200.md) | [83.3](/filings/0001477720-25-000237.md) | [84.2 d](/filings/0001477720-26-000021.md) | [75.1](/filings/0001477720-26-000039.md) | [79.4](/filings/0001477720-26-000060.md) | [73.8](/filings/0001477720-25-000237.md) | [73.2 d](/filings/0001477720-26-000021.md) | [66.1](/filings/0001477720-26-000039.md) | [81.7](/filings/0001477720-26-000060.md) |
| Operating income | $m | [(63.4)](/filings/0001477720-24-000107.md) | [(67.9) d](/filings/0001477720-26-000021.md) | [(66.2)](/filings/0001477720-25-000107.md) | [(76.8)](/filings/0001477720-25-000200.md) | [(60.2)](/filings/0001477720-25-000237.md) | [(63.6) d](/filings/0001477720-26-000021.md) | [(43.9)](/filings/0001477720-26-000039.md) | [(49.5)](/filings/0001477720-26-000060.md) | [(70.0)](/filings/0001477720-25-000237.md) | [(34.0) d](/filings/0001477720-26-000021.md) | [(15.2)](/filings/0001477720-26-000039.md) | [(41.2)](/filings/0001477720-26-000060.md) |
| Interest expense | $m | [1.0](/filings/0001477720-23-000053.md) | [1.0 d](/filings/0001477720-24-000011.md) | [0.9](/filings/0001477720-25-000107.md) | [1.0](/filings/0001477720-25-000200.md) | [0.9](/filings/0001477720-25-000237.md) | [0.9 d](/filings/0001477720-26-000021.md) | [0.8](/filings/0001477720-26-000039.md) | [0.8](/filings/0001477720-26-000060.md) | [0.8](/filings/0001477720-25-000237.md) | [0.8 d](/filings/0001477720-26-000021.md) | [0.6](/filings/0001477720-26-000039.md) | [0.6](/filings/0001477720-26-000060.md) |
| Income tax | $m | [0.8](/filings/0001477720-24-000107.md) | [0.8 d](/filings/0001477720-26-000021.md) | [1.0](/filings/0001477720-25-000107.md) | [1.2](/filings/0001477720-25-000200.md) | [1.2](/filings/0001477720-25-000237.md) | [1.4 d](/filings/0001477720-26-000021.md) | [1.2](/filings/0001477720-26-000039.md) | [1.4](/filings/0001477720-26-000060.md) | [1.3](/filings/0001477720-25-000237.md) | [1.0 d](/filings/0001477720-26-000021.md) | [1.4](/filings/0001477720-26-000039.md) | [(0.8)](/filings/0001477720-26-000060.md) |
| Net income | $m | [(61.8)](/filings/0001477720-24-000107.md) | [(62.4) d](/filings/0001477720-26-000021.md) | [(63.7)](/filings/0001477720-25-000107.md) | [(72.2)](/filings/0001477720-25-000200.md) | [(57.3)](/filings/0001477720-25-000237.md) | [(62.3) d](/filings/0001477720-26-000021.md) | [(40.0)](/filings/0001477720-26-000039.md) | [(48.4)](/filings/0001477720-26-000060.md) | [(68.4)](/filings/0001477720-25-000237.md) | [(32.2) d](/filings/0001477720-26-000021.md) | [(14.4)](/filings/0001477720-26-000039.md) | [(39.2)](/filings/0001477720-26-000060.md) |
| Diluted EPS | $ per share | [(0.28)](/filings/0001477720-24-000107.md) | not reported | [(0.28)](/filings/0001477720-25-000107.md) | [(0.31)](/filings/0001477720-25-000200.md) | [(0.25)](/filings/0001477720-25-000237.md) | not reported | [(0.17)](/filings/0001477720-26-000039.md) | [(0.20)](/filings/0001477720-26-000060.md) | [(0.29)](/filings/0001477720-25-000237.md) | not reported | [(0.06)](/filings/0001477720-26-000039.md) | [(0.17)](/filings/0001477720-26-000060.md) |
| Basic EPS | $ per share | [(0.28)](/filings/0001477720-24-000107.md) | not reported | [(0.28)](/filings/0001477720-25-000107.md) | [(0.31)](/filings/0001477720-25-000200.md) | [(0.25)](/filings/0001477720-25-000237.md) | not reported | [(0.17)](/filings/0001477720-26-000039.md) | [(0.20)](/filings/0001477720-26-000060.md) | [(0.29)](/filings/0001477720-25-000237.md) | not reported | [(0.06)](/filings/0001477720-26-000039.md) | [(0.17)](/filings/0001477720-26-000060.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [268](/filings/0001477720-24-000107.md) | [237](/filings/0001477720-26-000021.md) | [222](/filings/0001477720-25-000107.md) | [219](/filings/0001477720-25-000200.md) | [197](/filings/0001477720-25-000237.md) | [185](/filings/0001477720-26-000021.md) | [194](/filings/0001477720-26-000039.md) | [184](/filings/0001477720-26-000060.md) | [183](/filings/0001477720-25-000237.md) | [200](/filings/0001477720-26-000060.md) | [194](/filings/0001477720-26-000039.md) | [220](/filings/0001477720-26-000060.md) |
| Current assets | $m | [644](/filings/0001477720-23-000053.md) | [660](/filings/0001477720-25-000045.md) | [674](/filings/0001477720-24-000028.md) | [640](/filings/0001477720-24-000078.md) | [571](/filings/0001477720-24-000107.md) | [601](/filings/0001477720-26-000021.md) | [588](/filings/0001477720-25-000107.md) | [599](/filings/0001477720-25-000200.md) | [587](/filings/0001477720-25-000237.md) | [593](/filings/0001477720-26-000060.md) | [550](/filings/0001477720-26-000039.md) | [472](/filings/0001477720-26-000060.md) |
| Total assets | $m | [948](/filings/0001477720-23-000053.md) | [962](/filings/0001477720-25-000045.md) | [978](/filings/0001477720-24-000028.md) | [945](/filings/0001477720-24-000078.md) | [874](/filings/0001477720-24-000107.md) | [891](/filings/0001477720-26-000021.md) | [877](/filings/0001477720-25-000107.md) | [883](/filings/0001477720-25-000200.md) | [840](/filings/0001477720-25-000237.md) | [844](/filings/0001477720-26-000060.md) | [806](/filings/0001477720-26-000039.md) | [816](/filings/0001477720-26-000060.md) |
| Current liabilities | $m | [343](/filings/0001477720-23-000053.md) | [367](/filings/0001477720-25-000045.md) | [394](/filings/0001477720-24-000028.md) | [393](/filings/0001477720-24-000078.md) | [383](/filings/0001477720-24-000107.md) | [416](/filings/0001477720-26-000021.md) | [399](/filings/0001477720-25-000107.md) | [424](/filings/0001477720-25-000200.md) | [421](/filings/0001477720-25-000237.md) | [501](/filings/0001477720-26-000060.md) | [480](/filings/0001477720-26-000039.md) | [513](/filings/0001477720-26-000060.md) |
| Total liabilities | $m | [616](/filings/0001477720-23-000053.md) | [636](/filings/0001477720-25-000045.md) | [658](/filings/0001477720-24-000028.md) | [653](/filings/0001477720-24-000078.md) | [635](/filings/0001477720-24-000107.md) | [664](/filings/0001477720-26-000021.md) | [641](/filings/0001477720-25-000107.md) | [659](/filings/0001477720-25-000200.md) | [652](/filings/0001477720-25-000237.md) | [690](/filings/0001477720-26-000060.md) | [669](/filings/0001477720-26-000039.md) | [712](/filings/0001477720-26-000060.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001477720-26-000021.md) | not reported | not reported | not reported | [40.8](/filings/0001477720-26-000060.md) | [38.3](/filings/0001477720-26-000039.md) | [37.1](/filings/0001477720-26-000060.md) |
| Shareholders' equity | $m | [332](/filings/0001477720-24-000107.md) | [326](/filings/0001477720-26-000021.md) | [320](/filings/0001477720-25-000200.md) | [292](/filings/0001477720-25-000237.md) | [239](/filings/0001477720-25-000237.md) | [228](/filings/0001477720-26-000060.md) | [236](/filings/0001477720-26-000060.md) | [225](/filings/0001477720-26-000060.md) | [188](/filings/0001477720-25-000237.md) | [154](/filings/0001477720-26-000060.md) | [137](/filings/0001477720-26-000060.md) | [104](/filings/0001477720-26-000060.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.2) d](/filings/0001477720-24-000107.md) | [(15.3) d](/filings/0001477720-26-000021.md) | [(1.9)](/filings/0001477720-25-000107.md) | [15.9 d](/filings/0001477720-25-000200.md) | [(14.9) d](/filings/0001477720-25-000237.md) | [15.9 d](/filings/0001477720-26-000021.md) | [6.8](/filings/0001477720-26-000039.md) | [39.8 d](/filings/0001477720-26-000060.md) | [16.2 d](/filings/0001477720-25-000237.md) | [27.6 d](/filings/0001477720-26-000021.md) | [40.2](/filings/0001477720-26-000039.md) | [46.0 d](/filings/0001477720-26-000060.md) |
| Capital expenditure | $m | [1.3 d](/filings/0001477720-24-000107.md) | [0.5 d](/filings/0001477720-26-000021.md) | [1.0](/filings/0001477720-25-000107.md) | [1.7 d](/filings/0001477720-25-000200.md) | [1.4 d](/filings/0001477720-25-000237.md) | [1.5 d](/filings/0001477720-26-000021.md) | [0.6](/filings/0001477720-26-000039.md) | [1.3 d](/filings/0001477720-26-000060.md) | [0.7 d](/filings/0001477720-25-000237.md) | [1.2 d](/filings/0001477720-26-000021.md) | [2.8](/filings/0001477720-26-000039.md) | [1.5 d](/filings/0001477720-26-000060.md) |
| Share repurchases | $m | [0.0 d](/filings/0001477720-24-000107.md) | [0.0 d](/filings/0001477720-26-000021.md) | [0.0](/filings/0001477720-25-000107.md) | [19.0 d](/filings/0001477720-25-000200.md) | [54.8 d](/filings/0001477720-25-000237.md) | [4.5 d](/filings/0001477720-26-000021.md) | [14.5](/filings/0001477720-26-000039.md) | [28.9 d](/filings/0001477720-26-000060.md) | [30.8 d](/filings/0001477720-25-000237.md) | [58.0 d](/filings/0001477720-26-000021.md) | [45.0](/filings/0001477720-26-000039.md) | [51.5 d](/filings/0001477720-26-000060.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [205](/filings/0001477720-23-000053.md) | [216](/filings/0001477720-24-000028.md) | [219](/filings/0001477720-24-000078.md) | [222](/filings/0001477720-24-000107.md) | [227](/filings/0001477720-25-000107.md) | [230](/filings/0001477720-25-000200.md) | [230](/filings/0001477720-25-000237.md) | [235](/filings/0001477720-26-000039.md) | [236](/filings/0001477720-26-000060.md) | [238](/filings/0001477720-25-000237.md) | [238](/filings/0001477720-26-000039.md) | [231](/filings/0001477720-26-000060.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.